Predictive Oncology Stock (NASDAQ: POAI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 494.000 / 174.001K |
Day Range | - - - |
52 Wk Range | 1.120 - 7.120 |
Market Cap | $6.850M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 0.32% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Predictive Oncology (NASDAQ: POAI) through any online brokerage.
Other companies in Predictive Oncology’s space includes: Catheter Precision (AMEX:VTAK), ENDRA Life Sciences (NASDAQ:NDRA), Nexalin Technology (NASDAQ:NXL), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Predictive Oncology (NASDAQ: POAI) was reported by HC Wainwright & Co. on Wednesday, June 30, 2021. The analyst firm set a price target for 5.00 expecting POAI to rise to within 12 months (a possible 199.40% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Predictive Oncology (NASDAQ: POAI) is $1.67 last updated Today at May 14, 2024 at 7:02 AM EDT.
There are no upcoming dividends for Predictive Oncology.
Predictive Oncology’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Predictive Oncology.
Predictive Oncology is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.